Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Colorcon
Medtronic
McKinsey
Merck

Last Updated: June 27, 2022

HYDROCODONE BITARTRATE AND ACETAMINOPHEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Hydrocodone Bitartrate And Acetaminophen, and when can generic versions of Hydrocodone Bitartrate And Acetaminophen launch?

Hydrocodone Bitartrate And Acetaminophen is a drug marketed by Mallinckrodt, Mikart, Chartwell, Genus, Mallinckrodt Inc, Nesher Pharms, Pharm Assoc, Tris Pharma Inc, Vintage Pharms, Vistapharm, Wes Pharma Inc, Abhai Llc, Able, Actavis Labs Fl Inc, Alvogen, Amneal Pharms, Amneal Pharms Ny, Anda Repository, Apil, Ascent Pharms Inc, Aurolife Pharma Llc, Barr, Caraco, Cerovene Inc, Epic Pharma Llc, Granules, Halsey, Ivax Pharms, Lannett Co Inc, Mutual Pharm, Nostrum Labs Inc, Novel Labs Inc, Prinston Inc, Ranbaxy, Ranbaxy Labs Ltd, Rhodes Pharms, Sandoz, Specgx Llc, Strides Pharma, Sun Pharm Inds Inc, Sun Pharm Inds Ltd, Ucb Inc, Upsher Smith Labs, Usl Pharma, Vintage Pharms Llc, Watson Labs, and Watson Labs Florida. and is included in one hundred and twenty-six NDAs.

The generic ingredient in HYDROCODONE BITARTRATE AND ACETAMINOPHEN is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.

Drug patent expirations by year for HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Recent Clinical Trials for HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sun Pharma Advanced Research Company LimitedPhase 1
GrĂ¼nenthal GmbHPhase 1
Teva Branded Pharmaceutical Products, R&D Inc.Phase 3

See all HYDROCODONE BITARTRATE AND ACETAMINOPHEN clinical trials

Pharmacology for HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Drug ClassOpioid Agonist
Mechanism of Action Opioid Agonists
Anatomical Therapeutic Chemical (ATC) Classes for HYDROCODONE BITARTRATE AND ACETAMINOPHEN

US Patents and Regulatory Information for HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurolife Pharma Llc HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 201013-003 Apr 11, 2012 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Granules HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 211729-002 Jan 3, 2020 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Actavis Labs Fl Inc HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 206470-002 Jun 2, 2016 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Johnson and Johnson
Dow
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.